Research ArticleDrug Discovery and Translational Medicine
Synergistic antiproliferative activity of the RAD51 inhibitor IBR2 with inhibitors of receptor tyrosine kinases and microtubule protein
Peter J Ferguson, Mark D Vincent and James Koropatnick
Journal of Pharmacology and Experimental Therapeutics October 23, 2017, jpet.117.241661; DOI: https://doi.org/10.1124/jpet.117.241661